Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.

Pune, Oct. 18, 2024 (GLOBE NEWSWIRE) -- The SNS Insider report indicates that, “ The Liver Biopsy Market size was about USD 0 ...

Unfortunately, this exquisite organ can be impacted by primary liver cancer originating within itself or by secondary cancer ...

Hepatic Disease: A Camu-Camu Fruit Extract to Reduce Liver Fat Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

https://gco.iarc.who.int/media/globocan/factsheets/populations/356-india-fact-sheet.pdf ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

An investigational oral fatty acid synthase (FASN) inhibitor was associated with significant improvements in metabolic ...

Glycated haemoglobin may predict disease severity in patients with NAFLD, a study published in the Diabetes Research and ...

Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...